Indirect markers of fibrosis in chronic liver diseases: Is aspartate transaminase-to-platelet ratio (APRI) a useful test?

AUTHORS

Claudia Della Corte 1 , Anna Alisi 1 , Valerio Nobili 2 , *

1 Unit of Liver Research of Bambino Gesu Children's Hospital, Italy

2 Unit of Liver Research of Bambino Gesu Children's Hospital, [email protected], Italy

How to Cite: Della Corte C, Alisi A, Nobili V. Indirect markers of fibrosis in chronic liver diseases: Is aspartate transaminase-to-platelet ratio (APRI) a useful test?, Hepat Mon. Online ahead of Print ; 11(7):558-559.

ARTICLE INFORMATION

Hepatitis Monthly: 11 (7); 558-559
Article Type: Letter
Received: April 7, 2011
Accepted: April 12, 2011

Crossmark

CHEKING

READ FULL TEXT
Abstract

This article does not have abstract.

Keywords

Fibrosis Liver diseases NAFLD

© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Full Text

Full text is available in PDF

COMMENTS

LEAVE A COMMENT HERE: